SCHEMBL31435231

SCHEMBL31435231

C[C@H]1C[C@@H](C(=O)Nc2cccc(C(F)(F)F)c2)CCN1Cc1noc(-c2ccc(F)c(C(F)(F)F)c2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2M P61081 3/20 0.46
DCUN1D1 Q96GG9 3/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 4/20 0.45
KDM4E B2RXH2 3/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
USP2 O75604 2/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ACKR3 P25106 4/20 0.44
MAPT P10636 4/20 0.40
RECQL P46063 1/20 0.40
EPHX2 P34913 1/20 0.40
ALOX15 P16050 1/20 0.39
TP53 P04637 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31435225 1.00 UBE2M (0.46) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435222 1.00 UBE2M (0.46) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435245 0.91 UBE2M (0.45) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435221 0.91 UBE2M (0.50) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435232 0.91 MEN1 (0.44) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435252 0.91 ACKR3 (0.38) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435233 0.91 ACKR3 (0.38) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435260 0.90 UBE2M (0.43) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435244 0.90 UBE2M (0.43) UBE2MDCUN1D1MEN1KMT2AALDH1A1
SCHEMBL31435236 0.90 UBE2M (0.43) UBE2MDCUN1D1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090928-A1 COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AQUINNAH PHARMACEUTICALS, INC. (US) 2025-05-01 WO claimed
WO-2025090928-A1 COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AQUINNAH PHARMACEUTICALS, INC. (US) 2025-05-01 WO disclosed